In bladder cancer, PTK7 aptamer-Gemcitabine conjugate (PTK7-GEMs) specifically bind to cancer cells dependent on the expression levels of PTK7 and PTK7-GEMs showed more robust anti-tumor efficacy and excellent biosafety in tumor xenograft mice models (122). This evidence concerns the gene PTK7 and urinary bladder cancer.